Grants and Contracts
Congratulations to the following individuals for obtaining extramural funding from federal, state, and/or independent sources between February 1 and April 30, 2024!
NOTE: If any information has been inadvertently omitted, please contact the editor (dflock@lsuhsc.edu) and a correction will be printed in the next issue of The Pulse.
National Institutes of Health – F32
Lisa Wilson, PhD (Physiology)
“Adolescent Opioid Exposure Effects on Alcohol-Induced Hyperalgesia in Adult Mice”
National Institutes of Health – T35
Patricia Molina, MD, PhD (Physiology)
Renewed: “Medical Student Alcohol Research Internship (MSARI)”
National Institutes of Health – R01 (sub-award)
Eric Lazartigues, PhD (Cardiovascular Center of Excellence)
“Insulin-like Growth Factor-1 and Atherosclerosis”
National Institutes of Health/NIAID
Shelby MacRae, MD (Medicine/Pulmonary-Critical Care) and Juzar Ali, MD (Medicine/Pulmonary-Critical
Care)
“Non-TB Mycobacterial disease (NTM) Data Portal Project”
National Science Foundation
Fern Tsien, PhD (Genetics); Co-PI: Kelly Sherman, PhD (Pharmacology); Senior Key Personnel
and Program Co-Director: Hamilton Farris, PhD (Neuroscience Center of Excellence)
“REU Sites: Research Experiences for Undergraduates in Genomics and Neurosciences”
Virginia Ronchi, PhD (Genetics)
“Absolute Protein Quantitation In Vitro Diagnostics for Gut Inflammation”
LA Department of Veteran Affairs
Vahideh Tarhriz, PhD (Cardiovascular Center of Excellence)
“Southeast Louisiana Vets COVID”
Pharmaceutical, Professional Society and Private Grants
Ifechukwude Joachim Biose, PhD (Pharmacology)
Pennington Biomedical Research Center/LAUNCHED
“Understanding the Neural Basis of Obesity in Novel Mouse Model”
Michael Hagensee, MD, PhD (Microbiology, Immunology, and Parasitology)
American Cancer Society
“Improving Cervical Cancer Prevention in Louisiana”
Jesus Jaile, MD (Pediatrics)
Society of Pediatric Cardiology
“Training Program Directors Travel Grant”
Rebecca Lillis, MD (Medicine/Infectious Diseases)
MetaboliteDX Corp.
“Development of Small Biomarker-Based Diagnostics for Bacterial Vaginosis”
Omeed Moaven, MD (Surgery)
SFA Therapeutics
“SFA Therapeutics Spec Testing”
Rajesh Mohandas, MD (Medicine/ Nephrology and Hypertension)
Bayer Healthcare Pharmaceuticals
“A Parallel-Group, Phase 2, Double-Blind, Three-Arm Study to Assess Efficacy and Safety
of Finerenone Plus Empagliflozin Compared with Either Finerenone or Empagliflozin
in Participants with Chronic Kidney Disease and Type 2 Diabetes”
Rajesh Mohandas, MD (Medicine/ Nephrology and Hypertension)
Mineralys Therapeutics, Inc.
“A Phase 2 Study to Evaluate the Efficacy and Safety of Lorundrostat, a Selective
Aldosterone Synthase Inhibitor Alone, and in a Combination with the Sglt2 Inhibitor
Dapagliflozin, in Adults with Chronic Kidney Disease”
Rajesh Mohandas, MD (Medicine/ Nephrology and Hypertension)
Pathalys Pharma, Inc.
“A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy
and Safety of Dose-Titrated PLS240 in the Treatment of Secondary Hyperparathyroidism
in Individuals with End Stage Kidney Disease on Hemodialysis”
Piotr Olejniczak, MD, PhD (Neurology)
Biohaven Pharmaceuticals, Inc.
“A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate
the Efficacy, Safety and Tolerability of Adjunctive Treatment with BHV-7000 in Subjects
with Focal Onset Epilepsy”
Marlow Taylor, MD (Psychiatry)
American Academy of Child and Adolescent Psychiatry
“Equipping School Educators and Staff with Practical Knowledge in the Administration
and Use of Naloxone”